ALKERMES | ALKS - 股本和储备

金融业

USD

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 7.56B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	股本和储备	更改		日
AbbVie	USD -5.94B		721M	2026-06
Acadia Pharmaceuticals	USD 1.31B		58.54M	2026-06
ALKERMES	USD 1.81B		57.02M	2026-06
Amgen	USD 11.69B		2.5B	2026-06
Biogen	USD 18.85B		196.3M	2026-06
BioMarin Pharmaceutical	USD 6.32B		109.58M	2026-06
Bristol-Myers Squibb	USD 22.32B		2.25B	2026-06
Coherus Biosciences	USD 60.84M		17.78M	2026-06
Eli Lilly	USD 33.88B		2.68B	2026-06
Gilead Sciences	USD 11.74B		11.77B	2026-06
Heron Therapeutics	USD 6.91M		2.23M	2026-06
Ionis Pharmaceuticals	USD 439.74M		51.68M	2026-06
J&J	USD 84.97B		3.78B	2026-06
Malin Corporation	EUR 193.2M		75M	2024-12
Merck	USD 41.93B		3.94B	2026-06
Minerva Neurosciences	USD -140.75M		106.17M	2025-12
Nektar Therapeutics	USD 576.22M		486.38M	2026-03
Neurocrine Biosciences	USD 3.69B		286.2M	2026-06
Otsuka Holdings	JPY 3.24T		131.63B	2026-06
Ovoca Bio	EUR 780K		485K	2025-12
Pfizer	USD 85.19B		4.91B	2026-06
Regeneron Pharmaceuticals	USD 31.71B		287.8M	2026-06
Vertex Pharmaceuticals	USD 20.25B		886M	2026-06